SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDerwent London Regulatory News (DLN)

Share Price Information for Derwent London (DLN)

Share Price is delayed by 15 minutes
Get Live Data
1,881.00    38.00 (2.06%)
Bid:
1,889.00
Ask:
1,893.00
Spread: 4.00 (0.212%)
Market Cap: £2.10b
DLN Live PriceLast checked at - London Stock Exchange

Intraday Derwent London Share Chart

Director/PDMR Shareholding

21 May 2026 17:15

RNS Number : 3440F
Derwent London PLC
21 May 2026
 

21 May 2026

Derwent London plc ("Derwent London" / "the Group")

Notification of interests of Directors and Persons DischargingManagerial Responsibility ("PDMR")

The Group announces the following changes to the interests of Directors in the Group's ordinary shares of 5p each (the 'Shares').

Grant of Awards

On 21 May 2026, the Group granted share-based awards (the 'Awards') under the Derwent London Performance Share Plan 2023 (the 'Plan') to certain Directors of the Group (who are Persons Discharging Managerial Responsibilities), as follows:

 

Name

Role

Type of Award

Number of shares

Damian M A Wisniewski

Chief Financial Officer

Performance Share Award

49,905

Restricted Share Award

8,317

Emily J Prideaux

Director

Performance Share Award

49,905

Restricted Share Award

8,317

 

Awards granted under the Plan are structured as nil cost options and will vest on 21 May 2029. The number of Awards granted are taken as a percentage of salary, with 150% of salary for the Performance Share Awards and 25% for the Restricted Share Awards.

Vesting of Performance Share Awards depends on the extent to which the performance conditions are satisfied, being performance metrics and targets related to total shareholder return, total property return and embodied carbon intensity.

Vesting of Restricted Share Awards depends on the performance underpins being achieved, namely no breach of financial covenants, satisfactory underlying performance and no material failure resulting in significant reputational damage and/or financial loss.

The performance period for the Awards commenced on 1 January 2026 and will end on 31 December 2028.

Following vesting and subject to the Group's share dealing procedures, Awards under the Plan can be exercised in accordance with the rules of the Plan.

The Directors are each required to retain their net of tax liability number of vested Shares (if any) delivered under their Award for at least two years from the point of vesting (the 'Holding Period') and are each entitled to additional vesting shares for dividend equivalents in respect of dividends paid on vested shares between the grant date and the date of vesting.

The Awards remain subject to the malus and clawback provisions of the Plan.

 

This announcement is made in accordance with Article 19 of the Market Abuse Regulation and Rule 3.1 of the Disclosure Guidance and Transparency Rules.

 

Notification of the transactions set out below was made to the Group on 21 May 2026.

 

For further information, please contact:

Derwent London

Tel: +44 (0)20 7659 3000

David Lawler, Company Secretary

 

The information set out below is provided in accordance with the requirements of the UK Market Abuse Regulation.

1.

Details the person discharging managerial responsibilities / person closely associated

a)

Name

Damian M A Wisniewski

2.

Reason for the notification

a)

Position / status

Chief Financial Officer

b)

Initial notification / Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

 Derwent London plc

b)

LEI

 213800BXKQ9KZNUR1M61

4.

Details of the transaction (s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

 5p Ordinary shares in Derwent London plc

 

GB0002652740

b)

Nature of the transaction

Grant of nil cost option awards under the Derwent London Performance Share Plan 2023.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

58,222

 

 

d)

Aggregated information

- Aggregated volume

- Price

 

Not applicable - single transaction

e)

Date of the transaction

21 May 2026

f)

Place of the transaction

Outside a trading venue

 

1.

Details the person discharging managerial responsibilities / person closely associated

a)

Name

Emily J Prideaux

2.

Reason for the notification

a)

Position / status

Director

b)

Initial notification / Amendment

Initial notification

 

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

 Derwent London plc

b)

LEI

 213800BXKQ9KZNUR1M61

4.

Details of the transaction (s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

 5p Ordinary shares in Derwent London plc

 

GB0002652740

b)

Nature of the transaction

Grant of nil cost option awards under the Derwent London Performance Share Plan 2023.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

58,222

 

 

d)

Aggregated information

- Aggregated volume

- Price

 

Not applicable - single transaction

e)

Date of the transaction

21 May 2026

f)

Place of the transaction

Outside a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFEEEVILFIR
Date   Source Headline
11th Jun 20267:00 amRNSDirectorate change
8th Jun 20267:00 amRNSTransaction in Own Shares
2nd Jun 20262:00 pmRNSHolding(s) in Company
1st Jun 20267:00 amRNSTransaction in Own Shares
29th May 20265:37 pmRNSTotal Voting Rights
26th May 20267:00 amRNSTransaction in Own Shares
21st May 20265:15 pmRNSDirector/PDMR Shareholding
19th May 202610:00 amRNSDirector Declaration
18th May 20267:00 amRNSTransaction in Own Shares
15th May 202611:45 amRNSResult of AGM
12th May 20267:00 amRNSTrading Statement
1st May 202610:30 amRNSHolding(s) in Company
30th Apr 20264:45 pmRNSTotal Voting Rights
22nd Apr 20265:00 pmRNSHolding(s) in Company
22nd Apr 202610:15 amRNSHolding(s) in Company
20th Apr 202610:30 amRNSHolding(s) in Company
14th Apr 202611:14 amRNSAnnual Financial Report
10th Apr 20264:45 pmRNSAdmission to Trading
7th Apr 20265:12 pmRNSEmployee Benefit Trust (“EBT”)
7th Apr 20264:45 pmRNSDirector/PDMR Shareholding
2nd Apr 20267:00 amRNSAppointment of Barclays as joint corporate broker
1st Apr 20267:00 amRNSDisposal of Horseferry House SW1
31st Mar 20264:45 pmRNSTotal Voting Rights
27th Mar 202612:45 pmRNSDirector/PDMR Shareholding
24th Mar 202610:30 amRNSDirector/PDMR Shareholding
20th Mar 20264:15 pmRNSDirector/PDMR Shareholding
16th Mar 20267:00 amRNSNetwork building fully pre-let
16th Mar 20267:00 amRNSNetwork building fully pre-let
27th Feb 20264:45 pmRNSTotal Voting Rights
26th Feb 20267:32 amRNSDerwent London plc Disposal of 90 Whitfield Street
26th Feb 20267:00 amRNSResults for the Year Ended 31 December 2025
6th Feb 20264:40 pmRNSHolding(s) in Company
6th Feb 20267:00 amRNSDisposal of 80-85 Tottenham Court Road W1
30th Jan 20264:45 pmRNSTotal Voting Rights
22nd Jan 20269:00 amRNSDirectorate change
15th Jan 202611:00 amRNSHolding(s) in Company
31st Dec 20251:15 pmRNSTotal Voting Rights
31st Dec 20251:15 pmRNSTotal Voting Rights
17th Dec 20257:00 amRNSPlanning success at Blue Star House SW9
9th Dec 20257:00 amRNSBurberry extends commitment to Horseferry House
28th Nov 20254:45 pmRNSTotal Voting Rights
6th Nov 20257:00 amRNSThird Quarter Business Update
31st Oct 20254:45 pmRNSTotal Voting Rights
21st Oct 20257:00 amRNSStrategic partnership at Old Street Quarter
9th Oct 20257:00 amRNSSuccessful completion of 25 Baker Street
30th Sep 20254:45 pmRNSTotal Voting Rights
30th Sep 202511:00 amRNSHolding(s) in Company
22nd Sep 202512:00 pmRNSBlock listing Interim Review
9th Sep 202511:45 amRNSDirector Declaration
2nd Sep 202511:30 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.